Found 5 matching trials
Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.
PHASE3Primary Objective : Compare the risk of occurrence of Grade3-4 cumulative p...
Location
Sanofi-Aventis Administrative Office
XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy
PHASE3Purpose of the trial is to evaluate the efficacy of Xaliproden in reducing ...
Location
Multiple Locations
Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens
PHASE3Primary objective:
To assess the effect of xaliproden hydrochloride (xalip...
Location
Sanofi-Aventis Administrative Office
Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
PHASE3The purpose of this study is to assess xaliproden's potential capacity of s...
Location
Neurological Physicians of Arizona, Inc.
18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
PHASE3The purpose of this study is to assess xaliproden's potential capacity of s...
Location
UAB Memory Disorders Clinic